Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 2, 2003, Pages 282-291

  Reza, Md Selim ^a   Quadir, Mohiuddin Abdul ^a   Haider, Syed Shabbir ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; DICLOFENAC; DILTIAZEM; HYDROCHLORIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; PHOSPHATE; PLASTIC; POLYMER; POLYVINYL ACETATE; POVIDONE; THEOPHYLLINE; WAX;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISSOLUTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG SOLUBILITY; DRUG TRANSPORT; HYDROPHILICITY; HYDROPHOBICITY; PHARMACOKINETICS; PHYSICAL CHEMISTRY; POLYMERIZATION; STATISTICAL SIGNIFICANCE; TABLET COMPRESSION; TABLET FORMULATION; TABLET MATRIX; TABLET POROSITY;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; POLYMERS;

EID: 0141764821     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Merkus, F.W.H.M., Controlled and rate-controlled drug delivery ; principal characteristics, possibilities and limitations, in Struyker-Boudier, H.A.J. (eds), Rate- Controlled Drug Administration and Action, CRC Press, Boca Raton, FL, USA, pp 15-47, 1986.
2. Cardinal, J.R., Matrix systems, in Langer R. S. and Wise D.L. (eds), Medical Applications of Controlled Release, Volume 1, Classes of Systems, CRC Press, Boca Raton, FL, USA, pp 41-67, 1984.
3. Lordi, N.G., Sustained Release Dosage Forms, in Lachman L: Lieberman H A and Kanig J L (eds), The Theory and Practice of Industrial Pharmacy. 3rd ed., Varghese Publishing House, Bombay, pp 430-456, 1990.
4. Talukder, M.M., Michoel, A., Rombaut, P. and Kinget, R., Comparative Study on Xanthun Gum and Hydroxypropylmethylcellulose as Matrices for Controlled-Release Drug Delivery I. Int J Pharm, 129: 231-241, 1996.
5. Bain, J.C., Tan, S.B., Ganderton, D. and Solomon, M.S., Comparison of the in vitro release characteristics of a wax matrix and a hydrogel sustained release diclofenac sodium tablet. Drug Dev Ind Pharm, 17: 215-232.
6. Lee, B.J., Ryu, S.G. and Cui, J.H., Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev Ind Pharm, 25 (4): 493-501, 1999.
7. The Dow Chemical Company, Formulation for controlled release with METHOCEL cellulose ethers, USA, 1987.
8. Cabelka, T.D. and Sheskey, P.J., Evaluation of granulation, excipient characteristics and drug solubility in the preparation of hydrophilic controlled-release matrix tablets. Dow Chemicals Publications,
9. Reza, M.S., Quadir, M.A. and Haider, S.S., Development of Theophylline Sustained Release Dosage Form Based on Kollidon SR. Pak J Pharm Sci , 2002. (Accepted)
10. Shao, Z.J., Farooqi, M.I., Diaz, S., Krishna, A.K. and Muhammad, NA., Effect of formulation variables and post-compression curing on drug release from a new sustained-release matrix material: polyvinylacetate-povidone. Pharm Dev Technol, 6(2): 247-254, 2001.
11. BASF, Technical Information, ME 397e, June 1999.
12. Dakkuri, A., Schroeder, H.G. and Deluca, P.P., Sustained release from inert matrixes II: effect of surfactants on Tripelennamine Hydrochloride release J Pharm Sci, 67: 354-357, 1978a
13. Al-Shora, H., Said, S. and Hammad, A.L., Sustained release from inert matrixes II. Effect of polyethylene glycols on theophylline release. Int J Pharm, 7: 77-82, 1980.
14. Goodhart, F.W., McCoy, R.H. and Ninger, G.C., Release of a water-soluble drug from wax matrix time-release tablets. J Pharm Sci, 63: 1748-1751, 1974.
15. Verma, P.R.P. and Banu, V., Sustained release of theophylline from eudragit RLPO and RSPO tablet. Drug Dev Ind Pharm, 22 (12): 1243-1247, 1996.
16. Chattaraj, S.C. and Das, S.K., Effect of formulation variables on dissolution profile of diclofenac sodium from ethyl- and hydroxypropylmethyl cellulose tablets. Drug Dev Ind Pharm, 22(7): 555-559, 1996.
17. Shah, D., Shah, Y. and Pradhan, R., Development and evaluation of controlled-release diltiazem HCl microparticles using cross-linked poly (vinyl alcohol). Drug Dev Ind Pharm, 23 (6): 567-574, 1997.
18. Ritger, P.L. and Peppas, N.A., A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Rel, 5: 37-42, 1987.
19. Shato, H., Miyagawa, Y., Okabe, T., Miyajima, M. and Sunada, H., Dissolution mechanism of diclofenac sodium from wax matrix granules. J Pharm Sci, 86 (8): 929-934, 1997.
20. Hakim, M.; Jalil, R., Evaluation of a New Rate Retarding Polymer Kollidon SR as Matrix Tablets. M.Pharm thesis, DU, Bangladesh , 2001.
21. Mockel, J.E. and Lippold, B.C., Zero-order release from hydrocolloid matrices. Pharm Res, 90 (7): 1066-1070, 1993.
22. Salsa, T., Veiga, F. and Pina, M.E., Oral controlled-release dosage forms.I. Cellulose ehter polymers in hydrophillic matrices. Drug Dev Ind Pharm, 23 (9): 929-938, 1997.
23. Monographs on drug substances: Diclofenac sodium, in Lund W (eds), The Pharmaceutical Codex. 12th ed., The Pharmaceutical Press, London, pp 835-838, 1994.
24. Sheu, M.T., Chou, H.L., Kao, C.C., Liu, C.H. and Sokoloski, T.D., Dissolution of diclofenac sodium from matrix tablets. Int J Pharm, 85: 57-63, 1992.
25. Billa, N., Yuen, K.H. and Peh, K.K., Diclofenac release from eudragit containing matrices and effect of thermal treatment. Drug Dev Ind Pharm, 24 (1): 45-50, 1998.
26. Alderman, D.A., A review of cellulose ethers in hydrophillic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr, 5(3): 1-9, 1984.
27. Li Wan Po, A., Wong, L.P. and Gilligan, C.A., Characterisation of commercially available theophylline sustained or controlled-release systems: in-vitro drug release profiles. Int J Pharm, 66: 111-130, 1990.
28. Boza, A., Caraballo, I., Alvarez-Fuentes, J. and Rabasco, A.M., Evaluation of eudragit® RS-PO and Ethocel ® 100 matrices for the controlled release of lobenzarit disodium. Drug Dev Ind Pharm, 25 (2): 229-233, 1999.
29. Nokhodchi, A., Farid, Dj., Najafi, M. and Adrangui, M., Studies on controlled release formulation of diclofenac sodium. Drug Dev Ind Pharm, 23 (11): 1019-1023, 1997.
30. Quadir, M.A., Reza, M.S. and Haider, S.S., Effect of polyethylene glycols on release of diclofenac sodium from directly compressed carnauba wax matrix tablets. J Bang Acad Sci, 26 (1): 1-8, 2002.
31. Sungthongjeen, S., Pitaksuteepong, T., Somsiri, A. and Sriamornsak, P., Studies on pectins as potential hydrogel matrices for controlled-release drug delivery. Drug Dev Ind Pharm, 25 (12): 1271-1276, 1999.
32. Wong, L.P., Gilligan, C.A. and Li Won Po, A., Preparation and characterisation of sustained-release ibuprofencetostearyl alcohol spheres. Int J Pharm, 83: 96-114, 1992.
33. Dakkuri, A., Butler, L.D. and Deluca, P.P., Sustained release from inert wax matrices III: Effect of povidone on tripellenamine hydrochloride release. J Pharm Sci, 67: 357-360, 1978a.
34. Dakkuri, A., Schroeder, H.G. and Deluca, P.P., Sustained release from inert wax matrices II: Effect of surfactants on tripellenamine hydrochloride release. J Pharm Sci, 67: 354-357, 1978b.
35. Schwartz, J.B., Simonelli, A.P. and Higuchi, W.I., Drug release from wax matrices I: Analysis of data with first order kinetics and with the diffusion controlled model. J Pharm Sci, 57: 274-277, 1968a.
36. Schwartz, J.B., Simonelli, A.P. and Higuchi, W.I., Drug release from wax matrices II: Application of a mixture theory to the sulfanilamide-wax system. J Pharm Sci, 57: 278-282, 1968b.
37. Goodhart, F.W., McCoy, R.H. and Ninger, F.C., Release of a water-soluble drug from a wax matrix timed-release tablet. J Pharm Sci, 63: 1748-1751, 1974.
38. Parab, P.V., Oh, C.K. and Ritschel, W.A., Sustained release from Precirol® (glycerol palmito-stearate) matrix: Effects of mannitol and hydroxypropyl methylcellulose on the release of theophylline. Drug Dev Ind Pharm, 12: 1309-1327, 1986.
39. Peterlin, A., Diffusion with discontinuous swelling. VI. Type II diffusion in spherical particles. Polym Eng Sci, 20: 238-251, 1980.
40. Reza, M.S., Quadir, M.A. and Haider, S.S., Development of theophylline sustained release dosage form based on kollidon SR. Pak J Pharm Sci, 15(1): 63-70, 2002.